The Study By Manikant Singh
Search

Dengue

  • 0
  • 3035
Font size:
Print

Dengue

Context

  • Dengue is sweeping over Latin America. 

 

More on News

      • As per newspaper reports, more than 6 million cases were reported in the region that includes South America, Central America, Mexico, and the Caribbean, over a third more than the 4.4 million reported in all of 2023. 
      • Between 2000 and 2019, the World Health Organisation (WHO) reported a ten fold increase (from 500000 to 5.2 million) in the number of cases worldwide, with an unusual high in 2019.

 

Causes of Dengue

Climate Change and Rising Temperatures

      • Ideal Conditions for Mosquitoes: Soaring global temperatures have created favorable environments for mosquitoes to thrive.
      • Expanded Habitat: Most mosquito species prefer warmer temperatures, leading to increased breeding and survival areas, notably in Latin America and the Caribbean.
      • Extended Mosquito Season: Higher temperatures have prolonged the period when mosquitoes are active, facilitating the transmission of vector-borne diseases like dengue.

 

Impact of Extreme Weather Events

      • Multiplication of Mosquito Population: Extreme weather events, such as untimely rainfall, storms, flooding, and rising sea levels, create stagnant pools of water ideal for mosquito breeding.
      • Droughts and Water Collection: Droughts prompt people to collect and store water in containers, inadvertently creating breeding sites for mosquitoes.

 

Rapid Urbanization

      • Shantytowns as Breeding Grounds: Rapid urbanization, particularly in Latin America, results in the proliferation of shantytowns with abundant standing water, providing ample breeding grounds for mosquitoes.

 

Lack of High-Efficacy Dengue Vaccine

      • Absence of Effective Vaccination: The absence of a high-efficacy dengue vaccine on a large scale hampers efforts to control the spread of the disease.

 

Syndrome

Dengue, a mosquito-borne viral illness, can result in a spectrum of clinical presentations – from mild fever to severe hemorrhagic fever and potentially fatal dengue shock syndrome

  • Dengue Fever:

      • Dengue fever often starts with a sudden onset of high temperature, reaching 104°F (40°C) or higher.
      • Other common symptoms include severe headaches, eye pain, muscle and joint pain, exhaustion, and an overall feeling of malaise.
      • Patients may also develop a rash, nausea, vomiting, and minor bleeding symptoms like nosebleeds, gum bleeding, or easy bruising.
  • Dengue Hemorrhagic Fever (DHF):

      • It is a severe form of dengue having potentially fatal consequences due to increased vascular permeability, plasma leakage, and bleeding.
      • They are similar to those of conventional dengue fever, but they also include indicators of fluid accumulation, severe abdominal pain, fast breathing, and restlessness.
  • Dengue Shock Syndrome (DSS):

      • Dengue shock syndrome (DSS) is the most severe form of dengue. 
      • It is characterized by extensive plasma leakage that causes deep shock and eventually circulatory collapse.
      • The indicators of circulatory instability that are present in patients with DSS include a weak and fast pulse, narrowing pulse pressure, cold, clammy extremities, and impaired mental status.
  • Vaccines for Dengue

      • Qdenga: A Japanese-made vaccine, but its high price makes it inaccessible to many.
      • Dengvaxia: A French-made vaccine, only suitable for individuals who have previously had a dengue infection.

 

Best practices and international efforts to mitigate dengue and related diseases: 

  • World Health Organization’s Global Strategy Global Strategy for Dengue Prevention and Control (2012–2020): To 2020 to reduce the impact of dengue and related diseases.
  • Goals: To reduce dengue-related deaths by at least 50% and decrease the number of people getting sick with dengue by at least 25% by the year 2020.
  • National Vector Borne Disease Control Programme (NVBDCP): Began in 2003–04 to prevent and control diseases spread by vectors.
  • Diseases Covered: The programme targeted diseases such as Japanese Encephalitis (JE), Dengue, Kala–azar, Lymphatic Filariasis, Malaria, and Chikungunya.
  • It was later integrated into the National Health Mission, a comprehensive healthcare initiative in India.
Print
Apply What You've Learned.
Prev Post Piezoelectric Devices For Wearable Applications
Next Post Integrating Radiocarbon Data into Climate Models